A new approach to predict evolution of influenza viruses can enhance vaccine efficacy

December 7, 2015, University of Helsinki

New results from a study performed at the University of Helsinki suggest that genomic information from circulating influenza viruses can help in producing more efficient seasonal vaccines. The researchers were able to develop a simple approach for reliable real-time tracking and prediction of viral evolution based on whole-genome sequences of influenza viruses.

Influenza vaccines have been developed to prevent the yearly outbreaks of this respiratory illness and to protect people at risk from developing severe disease. In contrast to many other vaccines, need to be reformulated each year because circulating influenza viruses continuously evolve. This evolution is due to the ability of viruses to accumulate new mutations in their genome. Especially critical are those genomic regions that encode viral proteins recognized by the human immune system.

World Health Organization (WHO) is responsible for predicting the influenza that will be most common during the next season and for giving recommendations on the particular virus strains that should be used for producing the vaccines for the next . The effectiveness of the vaccines varies from year to year and was modest for the previous season. This could be due to antigenic mismatch between the circulating and the recommended by the WHO.

Researchers from the Institute for Molecular Medicine Finland, FIMM, the University of Helsinki, have now analysed thousands of complete genome sequences of influenza A(H1N1) and A(H3N2) strains representing different geographic regions. The study was done in collaboration with researchers from Singapore and United Kingdom. By utilizing biostatistical methods, the team was able to identify several genetic variants that changed the structure of the influenza proteins and that were present in surprisingly many of the strains studied.

"We named these characteristic variants as evolutionary markers as they seemed to contain valuable information regarding the viral evolution," explains Denis Kainov, the leader of the research team.

Furthermore, the group was able to show that both influenza subtypes acquired their own sets of these evolutionary markers. Importantly, many of these markers were not present in the virus strains used for the vaccine development during the last season.

"We believe that our results and methodology could further improve vaccine strain selection process and, thereby, enhance vaccine efficacy. Each year a substantial number of Finns gets influenza. We estimated that if the vaccination efficacy increases by 50%, this would save up to 8 000 people from getting the disease in Finland alone. Our team proposes using the strains containing all the identified evolutionary markers as vaccine candidates for upcoming seasons," Kainov continues.

Explore further: Scientists pinpoint mutations responsible for ineffective 2014-2015 flu vaccine

More information: Sergei S. Belanov et al. Genome-wide analysis of evolutionary markers of human influenza A(H1N1)pdm09 and A(H3N2) viruses may guide selection of vaccine strain candidates, Genome Biology and Evolution (2015). DOI: 10.1093/gbe/evv240

Related Stories

Scientists pinpoint mutations responsible for ineffective 2014-2015 flu vaccine

June 25, 2015
Viruses like influenza have the ability to mutate over time, and given that the flu vaccines administered during the 2014-2015 season were largely ineffective at preventing the spread of the flu, it appears the virus that ...

Enhanced flu protection: Adding a second strain of B flu lessens likelihood of mismatched vaccine

March 13, 2015
A flu vaccine given just under the surface of the skin that includes four strains of inactivated influenza could be more protective than a similar flu vaccine containing only three strains, Saint Louis University research ...

CDC tweaking flu vaccine for better protection

June 5, 2015
(HealthDay)—Having acknowledged that the 2014-2015 flu vaccine was mismatched to the circulating influenza strains, U.S. health officials have ramped up next season's shots for broader protection.

Influenza vaccines provide moderate protection throughout the entire flu season

August 24, 2015
Individuals who received the flu vaccine were protected for up to 6 months post-vaccination, the duration of most flu seasons, according to a study presented at the 2015 International Conference on Emerging Infectious Diseases.

Flu study, on hold, yields new vaccine technology

September 2, 2015
Vaccines to protect against an avian influenza pandemic as well as seasonal flu may be mass produced more quickly and efficiently using technology described today by researchers at the University of Wisconsin-Madison in the ...

FDA approves first 4-in-1 flu vaccine

February 29, 2012
Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Recommended for you

Deadly Rift Valley fever: New insight, and hope for the future

July 19, 2018
Health control measures alone could be ineffective in the long term fight against the deadly Rift Valley fever which affects both humans and animals, a new study in the journal PNAS reports.

New guidelines to diagnose, manage rare endocrine disorders

July 19, 2018
International guidelines have been published for the first time to help doctors around the globe diagnose and manage patients with a very rare set of endocrine diseases known as pseudohypoparathyroidism and its related disorders, ...

Overuse of antibiotics not what the doctor ordered

July 19, 2018
With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community ...

Alcohol-related cirrhosis deaths skyrocket in young adults

July 18, 2018
Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

Hidden blood in feces may signal deadly conditions

July 17, 2018
(HealthDay)—Even if it's not visible to the naked eye, blood in the stool can be serious—a sign of a potentially fatal disease other than colon cancer, new research suggests.

Childhood abuse linked to greater risk of endometriosis, study finds

July 17, 2018
Endometriosis, a painful condition that affects one in 10 reproductive-age women in the U.S., has been linked to childhood physical and sexual abuse, according to findings published today in the journal Human Reproduction.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.